Viveve Medical (VIVE) Competitors $0.0002 0.00 (0.00%) As of 04/17/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock VIVE vs. NMRD, UTRS, MOTS, DRTSW, ANZUW, IONM, ATAKW, BBLGW, BRSHW, and BRSHShould you be buying Viveve Medical stock or one of its competitors? The main competitors of Viveve Medical include Nemaura Medical (NMRD), Minerva Surgical (UTRS), Motus GI (MOTS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Assure (IONM), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), and Bruush Oral Care (BRSH). These companies are all part of the "medical equipment" industry. Viveve Medical vs. Nemaura Medical Minerva Surgical Motus GI Alpha Tau Medical Anzu Special Acquisition Corp I Assure Aurora Technology Acquisition Bone Biologics Bruush Oral Care Bruush Oral Care Viveve Medical (NASDAQ:VIVE) and Nemaura Medical (NASDAQ:NMRD) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, profitability, community ranking, risk, earnings, dividends and valuation. Does the media favor VIVE or NMRD? In the previous week, Viveve Medical's average media sentiment score of 0.00 equaled Nemaura Medical'saverage media sentiment score. Company Overall Sentiment Viveve Medical Neutral Nemaura Medical Neutral Which has more volatility & risk, VIVE or NMRD? Viveve Medical has a beta of 0.28, indicating that its stock price is 72% less volatile than the S&P 500. Comparatively, Nemaura Medical has a beta of 0.43, indicating that its stock price is 57% less volatile than the S&P 500. Do institutionals & insiders hold more shares of VIVE or NMRD? 4.4% of Nemaura Medical shares are held by institutional investors. 5.7% of Viveve Medical shares are held by insiders. Comparatively, 40.4% of Nemaura Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has better earnings & valuation, VIVE or NMRD? Viveve Medical has higher revenue and earnings than Nemaura Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViveve Medical$6.83M0.00N/AN/AN/ANemaura Medical$3.02K2.67-$14.14M-$0.390.00 Does the MarketBeat Community favor VIVE or NMRD? Viveve Medical received 307 more outperform votes than Nemaura Medical when rated by MarketBeat users. Likewise, 73.70% of users gave Viveve Medical an outperform vote while only 57.14% of users gave Nemaura Medical an outperform vote. CompanyUnderperformOutperformViveve MedicalOutperform Votes31173.70% Underperform Votes11126.30% Nemaura MedicalOutperform Votes457.14% Underperform Votes342.86% Is VIVE or NMRD more profitable? Company Net Margins Return on Equity Return on Assets Viveve MedicalN/A N/A N/A Nemaura Medical N/A N/A N/A SummaryNemaura Medical beats Viveve Medical on 4 of the 7 factors compared between the two stocks. Get Viveve Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for VIVE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VIVE vs. The Competition Export to ExcelMetricViveve MedicalElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$2,000.00$3.11B$5.31B$7.35BDividend YieldN/A1.82%5.45%4.31%P/E RatioN/A14.8721.9417.82Price / Sales0.0043.57380.9497.68Price / CashN/A44.0938.2634.64Price / BookN/A3.336.453.98Net IncomeN/A$94.03M$3.22B$247.81M7 Day PerformanceN/A0.10%5.85%3.19%1 Month PerformanceN/A-9.43%-9.55%-7.70%1 Year PerformanceN/A-20.15%11.83%1.49% Viveve Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VIVEViveve MedicalN/A$0.00flatN/A+0.0%$2,000.00$6.83M0.0070NMRDNemaura MedicalN/A$0.00flatN/A-99.8%$8,000.00$3,017.000.0040UTRSMinerva SurgicalN/AN/AN/AN/A$1,000.00$51.69M0.00160Gap DownMOTSMotus GIN/A$0.00flatN/A-99.9%$1,000.00$319,000.000.0030DRTSWAlpha Tau MedicalN/A$0.21+2.7%N/AN/A$0.00N/A0.0080Positive NewsANZUWAnzu Special Acquisition Corp IN/A$0.03flatN/AN/A$0.00N/A0.002IONMAssureN/AN/AN/AN/A$0.00$149,000.000.00130Upcoming EarningsATAKWAurora Technology AcquisitionN/A$0.01-5.0%N/A-62.3%$0.00N/A0.00N/AGap UpBBLGWBone BiologicsN/A$20.20-2.9%N/AN/A$0.00N/A0.002BRSHWBruush Oral CareN/AN/AN/AN/A$0.00$2.92M0.0011BRSHBruush Oral CareN/A$0.00+12.5%N/A-98.3%$0.00$2.92M0.0011 Related Companies and Tools Related Companies Nemaura Medical Competitors Minerva Surgical Competitors Motus GI Competitors Alpha Tau Medical Competitors Anzu Special Acquisition Corp I Competitors Assure Competitors Aurora Technology Acquisition Competitors Bone Biologics Competitors Bruush Oral Care Competitors Bruush Oral Care Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VIVE) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viveve Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viveve Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.